The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of the anti-cancer stem cell agent demcizumab (DEM) & gemcitabine (GEM) +/- paclitaxel protein bound particles (nab-paclitaxel) in pts with pancreatic cancer.
 
Manuel Hidalgo
No Relationships to Disclose
 
Prasad Cooray
No Relationships to Disclose
 
Michael B. Jameson
No Relationships to Disclose
 
Alfredo Carrato
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Celgene; Merck
Travel, Accommodations, Expenses - Merck; Roche
 
Francis Parnis
No Relationships to Disclose
 
Mark Jeffery
No Relationships to Disclose
 
Peter S. Grimison
No Relationships to Disclose
 
Robert J. Stagg
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Ann M. Kapoun
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Jakob Dupont
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Niall C. Tebbutt
No Relationships to Disclose